Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
Completed · Phase 1
Conditions studied: Hypogonadism
In brief
To further characterize the transfer potential of marketed testosterone gel and new 1.62% formulation.
Key facts
- Study ID
- NCT00998933
- Run by
- Solvay Pharmaceuticals
- People needed
- 24
- Starts
- 2009-10-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2009-11-25
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male and female volunteers, with a BMI 20-35 kg/m2 (males) and 20-30 kg/m2 (females).
You may not qualify if…
- Males: history, current or suspected prostate or breast cancer.
- Female: pregnant or lactating.
Where it is running
- Site 1 — Miami Gardens, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.